206 related articles for article (PubMed ID: 11408607)
1. The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning.
Goumain M; Voisin T; Lorinet AM; Ducroc R; Tsocas A; Rozé C; Rouet-Benzineb P; Herzog H; Balasubramaniam A; Laburthe M
Mol Pharmacol; 2001 Jul; 60(1):124-34. PubMed ID: 11408607
[TBL] [Abstract][Full Text] [Related]
2. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
[TBL] [Abstract][Full Text] [Related]
3. Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid secretion in the rat jejunum in vivo.
Souli A; Chariot J; Voisin T; Presset O; Tsocas A; Balasubramaniam A; Laburthe M; Rozé C
Peptides; 1997; 18(4):551-7. PubMed ID: 9210175
[TBL] [Abstract][Full Text] [Related]
4. Distribution of common peptide YY-neuropeptide Y receptor along rat intestinal villus-crypt axis.
Voisin T; Rouyer-Fessard C; Laburthe M
Am J Physiol; 1990 May; 258(5 Pt 1):G753-9. PubMed ID: 2159240
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of the rat intestinal crypt peptide YY receptor vs. the recombinant rat Y5 receptor.
Goumain M; Voisin T; Lorinet AM; Balasubramaniam A; Laburthe M
Eur J Pharmacol; 1998 Dec; 362(2-3):245-9. PubMed ID: 9874177
[TBL] [Abstract][Full Text] [Related]
6. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.
Goumain M; Voisin T; Lorinet AM; Laburthe M
Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR
Brain Res; 2005 May; 1043(1-2):139-44. PubMed ID: 15862527
[TBL] [Abstract][Full Text] [Related]
8. Identification of positions in the human neuropeptide Y/peptide YY receptor Y2 that contribute to pharmacological differences between receptor subtypes.
Fällmar H; Åkerberg H; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D
Neuropeptides; 2011 Aug; 45(4):293-300. PubMed ID: 21696823
[TBL] [Abstract][Full Text] [Related]
9. Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice.
Wang L; Gourcerol G; Yuan PQ; Wu SV; Million M; Larauche M; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2010 Jan; 298(1):G45-56. PubMed ID: 19892938
[TBL] [Abstract][Full Text] [Related]
10. Peptide YY (3-36) modulates intracellular calcium through activation of the phosphatidylinositol pathway in hippocampal neurons.
Domingues MF; de Assis DR; Piovesan AR; Belo CAD; da Costa JC
Neuropeptides; 2018 Feb; 67():1-8. PubMed ID: 29157865
[TBL] [Abstract][Full Text] [Related]
11. BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist.
Dumont Y; Cadieux A; Doods H; Pheng LH; Abounader R; Hamel E; Jacques D; Regoli D; Quirion R
Br J Pharmacol; 2000 Mar; 129(6):1075-88. PubMed ID: 10725255
[TBL] [Abstract][Full Text] [Related]
12. The functional investigation of a human adenocarcinoma cell line, stably transfected with the neuropeptide Y Y1 receptor.
Holliday ND; Cox HM
Br J Pharmacol; 1996 Sep; 119(2):321-9. PubMed ID: 8886416
[TBL] [Abstract][Full Text] [Related]
13. Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.
Gicquiaux H; Tschöpl M; Doods HN; Bucher B
Br J Pharmacol; 1996 Dec; 119(7):1313-8. PubMed ID: 8968537
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a Y1-preferring NPY/PYY receptor in HT-29 cells.
Mannon PJ; Mervin SJ; Sheriff-Carter KD
Am J Physiol; 1994 Nov; 267(5 Pt 1):G901-7. PubMed ID: 7977753
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
Gehlert DR; Schober DA; Beavers L; Gadski R; Hoffman JA; Smiley DL; Chance RE; Lundell I; Larhammar D
Mol Pharmacol; 1996 Jul; 50(1):112-8. PubMed ID: 8700103
[TBL] [Abstract][Full Text] [Related]
16. Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype.
Gerald C; Walker MW; Vaysse PJ; He C; Branchek TA; Weinshank RL
J Biol Chem; 1995 Nov; 270(45):26758-61. PubMed ID: 7592910
[TBL] [Abstract][Full Text] [Related]
17. Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo.
Malmström RE
Br J Pharmacol; 2001 Aug; 133(7):1073-80. PubMed ID: 11487518
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity studies including a Psi(CH(2)-NH) scan of peptide YY (PYY) active site, PYY(22-36), for interaction with rat intestinal PYY receptors: development of analogues with potent in vivo activity in the intestine.
Balasubramaniam A; Tao Z; Zhai W; Stein M; Sheriff S; Chance WT; Fischer JE; Eden PE; Taylor JE; Liu CD; McFadden DW; Voisin T; Roze C; Laburthe M
J Med Chem; 2000 Sep; 43(18):3420-7. PubMed ID: 10978189
[TBL] [Abstract][Full Text] [Related]
19. Receptors for peptide YY and neuropeptide Y on guinea pig pancreatic acini.
Huang SC; Tsai MF
Peptides; 1994; 15(3):405-10. PubMed ID: 7524045
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of Y receptors and signaling pathways in intestinal circular and longitudinal smooth muscle.
Misra S; Mahavadi S; Grider JR; Murthy KS
Regul Pept; 2005 Feb; 125(1-3):163-72. PubMed ID: 15582728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
